MRD ба CAR T-Cell эмчилгээний хоорондын хамаарлыг ойлгох
What is MRD in cancer treatment? Measurable Residual Disease, or MRD, is the name for the very few cancer cells that stay in the body after or during treatment. Flow cytometry, polymerase chain reaction (PCR), or next-generati..
Мэдрэлийн эмгэгийн үед мезенхимийн үүдэл эсийн эмчилгээ
Neurological diseases are big problems around the world because they cause a lot of death and disability. Traditional treatments haven't always worked, which has led to a change toward new methods like cell-based therapies. Beca..
Өнчин эмийн тэмдэглэгээг FDA-аас бүдүүн гэдэсний хорт хавдрын эмчилгээнд зориулж CART T-Cell Therapy A2B530-д өгсөн.
In March 2024, a news release said that A2B530 (A2 Biotherapeutics), a CAR T-cell therapy, had been given Orphan Drug Designation to treat colorectal cancer that expresses carcinoembryonic antigen (CEA) and has lost HLA-A*02 expr..
Iovance's Amtagvi нь хатуу хавдрын анхны Т эсийн эмчилгээ гэж USFDA-аас зөвшөөрөгдсөн
Iovance Biotherapeutics' first-of-its-kind immunotherapy was approved by the FDA. This means that T-cell therapy, which has changed the way some types of blood cancer are treated, can now be used directly on solid tumors.The drug..
Амивантамаб-vmjw нь EGFR экзон 20-ын мутацитай жижиг эсийн уушигны хорт хавдрын заалтыг USFDA-аас зөвшөөрсөн.
The Food and Drug Administration approved amivantamab-vmjw (Rybrevant, Janssen Biotech, Inc.) in combination with carboplatin and pemetrexed on March 1, 2024. Patients with epidermal growth factor receptor (EGFR) exon 20 insertio..
Хими эмчилгээтэй Осимертинибийг EGFR-мутацийн жижиг эсийн уушгины хорт хавдрын үед USFDA зөвшөөрсөн.
The Food and Drug Administration approved osimertinib (Tagrisso, AstraZeneca Pharmaceuticals LP) in combination with platinum-based chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (la/mNSC..
Lifileucel нь мэс засалгүй эсвэл үсэрхийлсэн меланомад USFDA-аас зөвшөөрөгдсөн
The Food and Drug Administration granted accelerated approval to lifileucel (Amtagvi, Iovance Biotherapeutics, Inc.) on February 16, 2024. This approval is for adult patients with unresectable or metastatic melanoma who have been..
Тепотиниб нь үсэрхийлсэн жижиг эсийн уушгины хорт хавдрын үед USFDA-аас зөвшөөрөгдсөн
The Food and Drug Administration officially approved tepotinib (Tepmetko, EMD Serono, Inc.) on February 15, 2024, for adult patients with metastatic non-small cell lung cancer (NSCLC) that had mesenchymal-epithelial transition (M..
Иринотекан липосом нь үсэрхийлсэн нойр булчирхайн аденокарциномын эхний үе шатанд хэрэглэхийг USFDA-аас зөвшөөрсөн.
The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pancreatic adenocarcinoma as the..
Эрдафитиниб нь орон нутгийн дэвшилтэт эсвэл үсэрхийлсэн шээсний булчирхайн хорт хавдрын үед USFDA-аас зөвшөөрөгдсөн.
Erdafitinib (Balversa, Janssen Biotech) was approved by the Food and Drug Administration on January 19, 2024, for adult patients with FGFR3 genetic changes who have locally advanced or metastatic urothelial carcinoma (mUC). Patie..